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In this issue of the Journal, 2 papers (1,2) address an im-
portant question: how can we use computed tomographic
coronary angiography (CTCA) to quantify prognosis and
stenosis in patients with coronary artery disease? Simple
coronary calcium scoring (CCS), using a technique proposed
by Agatston et al. (3) more than 2 decades ago provides
a straightforward numerical result that predicts coronary heart
disease events and mortality in both historical and contem-
porary cohorts (4,5). Compared to CCS, CTCA offers
higher spatial resolution plus the ability to identify both
coronary stenosis and plaque composition. This additional
information ought to contribute to risk prediction. What has
been lacking is an easy method to turn the CTCA data on
plaque extent, location, and severity into an accurate prog-
nostic assessment for an individual patient. This would be
important not only in providing incremental prognostic
information beyond CCS but also to those patients with
chest pain who undergo CTCA without CCS.See pages 460 and 468In symptomatic cohorts, CTCA improves the prediction
of events beyond clinical risk factors and CCS (6,7).
However, adding CTCA to CCS in asymptomatic patients
has not been found to enhance risk prediction (8). In
addition, adding CCS to CTCA for a symptomatic patient
is unlikely to inﬂuence clinical management, because CTCA
will demonstrate the presence and extent of calciﬁed and
noncalciﬁed plaque. Therefore, CCS in such patients
primarily provides only a numerical risk estimate and will
add to the radiation burden of the procedure. Although
methods to calculate a calcium score from CTCA data have
been proposed, these have not yet reached routine clinical
practice (9).
However, the identiﬁcation of plaque location and luminal
stenoses by CTCA has been shown to be prognostically
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to disclose.all-cause mortality varied from 0.3% for absent or minimal
coronary disease (stenosis <50%) to 15% for mild to mod-
erate left main coronary artery disease (10). Likewise, in
a study of 432 patients, van Werkhoven et al. (7) reported an
annualized event rate of 2.1% in those with nonsigniﬁcant
coronary artery disease compared with 5.9% in those with
stenoses >50%. Plaque burden, location, and composition
were independent predictors of events and provided addi-
tional prognostic value. Therefore, the information content
for prognosis is clearly present in CTCA; what is needed is
a simple numerical expression derived from the data.
Hadamitzky et al. (1) present a prognostic score for 2-year
mortality from CTCA derived from CONFIRM (Coronary
Computed Tomography Angiography Evaluation for Clin-
ical Outcomes: An International Multicenter Registry).
More than 20,000 patients (of whom more than 300 died
during the study period) were enrolled from 12 centers in 6
countries, enhancing the external validity of their ﬁndings
compared with earlier, smaller, single-site studies.
The analysis identiﬁed that lesions located in the proximal
to mid coronary segments and plaques containing calcium
were predictive of poorer outcomes. It is not surprising that
proximal disease is most signiﬁcant, because such lesions
would jeopardize a large amount of myocardium, thereby
predisposing to large areas of ischemia and infarction, with an
expected greater mortality risk if destabilized. Moreover, one
can have greater conﬁdence in the identiﬁcation of proximal
plaque and stenosis severity on the computed tomography
(CT) images, compared with the smaller, distal vessels that
may challenge the spatial resolution of the technique.
A model focusing on plaques containing calcium (mixed
or calciﬁed plaques) performed better than a model consid-
ering all plaques. These ﬁndings may partly relate to issues
with visualization of plaques by computed tomography.
The identiﬁcation of calciﬁed or mixed plaques is usually
unequivocal by computed tomography, whereas movement
or noise on a scan can lead to blurring of the coronary wall
and be mistaken for soft plaque.
The CONFIRM registry planned to “identify, quantify,
and integrate.ﬁndings by CTCA with demographic and
clinical data for reﬁnement of risk stratiﬁcation of persons
with suspected or known [coronary artery disease]” (11).
Hadamitzky et al. (1) admirably address these goals.
Crucially, an online tool (12) will allow readers to calculate
2-year mortality for a patient on the basis of both clinical risk
factors and the results of CTCA. For the ﬁrst time, CTCA
ﬁndings can easily and rapidly be combined with traditional
risk factors to provide an evidence-based numerical risk
estimate.
There are limitations to this study. The data were derived
from a registry, and therefore treatment, which could be
inﬂuenced by the CTCA results, was not speciﬁed or
mandated. Hence, patients with severe disease may have
undergone treatment, with a subsequent reduction of their
risk. Indeed, prior reports from the CONFIRM registry
indicate that more than 50% of patients with high-risk disease
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478underwent revascularization and that those who did had
a survival beneﬁt (hazard ratio: 0.38) (13). However, this
would bias the results in favor of the null hypothesis,
which makes the detection of a difference in mortality on
the basis of location and plaque composition even more
impressive.
A second report on CTCA in this issue addresses the
difﬁcult problem of intermediate-severity (30% to 69%)
coronary stenoses (2). The goal of CTCA is to exclude or
identify ﬂow-limiting coronary disease. In 3 large multicenter
trials, CTCA has demonstrated excellent negative predictive
value for severe coronary stenoses (89% to 99%), but this
sensitivity is balanced by moderate speciﬁcity and less
impressive positive predictive value (36% to 82%) (14–16).
Therefore, not every lesion that appears signiﬁcant
on CTCA will appear signiﬁcant on invasive coronary
angiography (ICA).
Stenosis severity on CTCA may be overestimated because
of limited spatial resolution, calcium, or movement artifacts.
The problem of determining the functional signiﬁcance of
a stenosis is not unique to CTCA. In the Fractional Flow
Reserve Versus Angiography for Multivessel Evaluation
study, almost 40% of angiographically signiﬁcant lesions
according to ICA were judged to be nonischemic by frac-
tional ﬂow reserve (FFR) (17). If signiﬁcant lesions cannot
be identiﬁed on the basis of anatomic appearance by ICA,
CTCA will also struggle because of inferior spatial and
temporal resolution.
Rather than using invasive ICA with FFR to determine
the functional signiﬁcance of an indeterminate stenosis
on CTCA, the traditional alternative would be a stress
imaging examination. However, a recent large study in-
dicated that the sensitivity of nuclear stress perfusion is
only 67%, making it difﬁcult to usefully apply this tech-
nique in these patients with a high pre-test probability of
severe stenoses. The same study showed that stress mag-
netic resonance imaging had higher sensitivity than
nuclear perfusion, but both options require the patient to
undergo a separate examination subsequent to computed
tomography (18).
Within the computed tomography lab, further options to
clarify the severity of a lesion include a CT stress perfusion
study, the calculation of noninvasive FFR from the CT
dataset, analysis of the contrast gradient along the coronary
segment, and quantitative assessment of the lesion. CT
stress perfusion typically requires a second dose of contrast
and radiation along with the administration of a vasodilator
(such as adenosine). Although not widely available, it may
increase the speciﬁcity and per patient accuracy of com-
puted tomography to 95% compared with ICA with FFR
(19). Values from CT FFR correlate well with invasive
FFR, but the process is computationally complex and
usually requires several hours on an off-site supercom-
puter (20). Analysis of the decrease in contrast intensity
(transluminal attenuation gradient) along a coronary seg-
ment affected by a signiﬁcant stenosis may be particularlyworthwhile in broad-detector scanners that can acquire
images with isotemporal resolution (21).
In this issue, Nakazato et al. (2) compare quantitative
measurements of luminal narrowing on computed tomog-
raphy with a novel parameter, percent aggregate plaque
volume (%APV), to identify intermediate lesions with
functional signiﬁcance deﬁned by invasive FFR.
Fifty-eight patients with intermediate stenoses (30% to
69%) from 2 centers underwent ICA and FFR assessment,
38% of whom had evidence of ischemia. Radiation doses
ranged from 2 to 10 mSv for the CT scans but were not
reported for ICA with FFR assessment. Standard mea-
surements of stenosis severity were acquired from the CT
data, including diameter stenosis, area stenosis, minimal
luminal diameter, and minimal luminal area. Aggregate
plaque volume was obtained by summing the plaque area in
the vessel wall from the ostium to the distal point of the
stenosis and provided an assessment of the total plaque
burden in that artery.
Neither diameter nor area stenosis differentiated between
ischemic and nonischemic lesions. However, functionally
signiﬁcant stenoses exhibited smaller minimal luminal di-
ameter, smaller minimal luminal area, and greater %APV;
importantly, %APV outperformed the other measurements.
Although the results from Nakazato et al. (2) are prom-
ising, this was a small study, and signiﬁcant time and ex-
pertise were required to calculate %APV. Furthermore, only
intermediate-severity lesions were examined. These ﬁndings
therefore need to be replicated in a broader range of patients
from multiple centers. Both studies show that whether clas-
sifying the severity of a stenosis or quantifying mortality risk,
when it comes to coronary plaque, more is more. Despite
limitations, these studies represent steps forward in the
growth of CTCA in daily clinical practice.
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